Neuropathological Evaluation Strategy for Nonclinical Developmental Neurotoxicity Study of Drugs

Qu Zhe; Lv Jianjun; Lin Zhi; Huo Guitao; Yang Yanwei; Zhang Di; Zhang Shuo; Huo Yan; Geng Xingchao; Wang Xue; Li Bo

doi:10.16153/j.1002-7777.2018.05.009

Qu Zhe, Lv Jianjun, Lin Zhi, Huo Guitao, Yang Yanwei, Zhang Di, Zhang Shuo, Huo Yan, Geng Xingchao, Wang Xue, Li Bo

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (5) : 624-630.

PDF(1123 KB)

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (5) : 624-630. DOI: 10.16153/j.1002-7777.2018.05.009

Research Progress

Neuropathological Evaluation Strategy for Nonclinical Developmental Neurotoxicity Study of Drugs

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 32(5): 624-630 https://doi.org/10.16153/j.1002-7777.2018.05.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1123 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export